Transvaginal reduction of an interstitial heterotopic pregnancy with preservation of the intrauterine gestation.
With use of transvaginal ultrasonographic guidance, cardiac activity in an interstitial heterotopic pregnancy at 7 weeks' gestation was terminated. The interstitial pregnancy resolved, and a healthy term infant was delivered. If an early diagnosis of an interstitial heterotopic pregnancy is made, selective reduction may allow preservation of the intrauterine gestation without surgery.
Baker
V L
VL
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, USA.
Givens
C R
CR
Cadieux
M C
MC
D000328:Adult; D005260:Female; D005307:Fertilization in Vitro / Q000009:adverse effects; D005313:Fetal Death / Q000503:physiopathology; D006321:Heart / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008727:Methotrexate / Q000494:pharmacology; D019384:Nucleic Acid Synthesis Inhibitors / Q000494:pharmacology; D011189:Potassium Chloride / Q000494:pharmacology; D011247:Pregnancy / Q000502:physiology*; D011256:Pregnancy Outcome; D018607:Pregnancy Reduction, Multifetal / Q000379:methods* / Q000592:standards; D011271:Pregnancy, Ectopic / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D016216:Ultrasonography, Prenatal / Q000379:methods*
D019384:Nucleic Acid Synthesis Inhibitors; D011189:Potassium Chloride; D008727:Methotrexate